# Nutrition in hereditary ATTR amyloidosis
Nutrition plays an underestimated role in hereditary ATTR amyloidosis. Research shows that malnutrition and low albumin status are associated with worse outcomes, and that oxidative stress contributes to the progression of amyloidosis. This tab covers which nutritional approaches have been investigated and what is known about them.
General nutritional status and protein intake
ProveniIncluded in official guidelines, or approved by EMA or FDA
Adequate protein intake and maintenance of a healthy body weight are not optional in ATTR amyloidosis. Research from 2026 shows that serum albumin levels are an important prognostic indicator: patients with lower albumin levels have worse survival chances. A prospective multicenter study (2025) also shows that malnutrition and physical frailty are directly associated with worse outcomes in cardiac ATTR.
This suggests that maintaining adequate nutritional status throughout the disease is important. Patients sometimes lose weight unintentionally, partly due to reduced appetite, gastrointestinal symptoms (especially in peripheral neuropathy) or autonomic dysfunction that makes eating difficult. A specialized dietitian can help adjust intake without additional burden.
Antioxidants and nutraceutical supplementation
ResearchediPositive results in clinical studies, not yet standard treatment
A 2024 review shows that oxidative stress plays a role in the progression of ATTR amyloidosis. This has led to interest in antioxidants and plant-based supplements that could counteract oxidative stress.
Studies suggest that certain antioxidants (such as polyphenols, vitamins C and E, and coenzyme Q10) could theoretically be protective, but solid clinical evidence in ATTR populations is still largely lacking. Some amyloidosis centers cautiously mention that optimal antioxidant status may be useful, but this is not on par with drug therapies. It is also important to realize that certain supplements can interfere with certain medications, especially medications that affect heart rhythm or blood thinners.
Gut bacteria and nutrient absorption (SIBO)
ResearchediPositive results in clinical studies, not yet standard treatment
A recent finding (2025) is that small intestinal bacterial overgrowth (SIBO) occurs relatively frequently in ATTR amyloidosis patients. This can disrupt intake and absorption of nutrients, particularly vitamin B12, fat and fat-soluble vitamins.
SIBO can manifest as bloating, diarrhea and malnutrition. Detection and treatment of it is therefore increasingly recognized as part of multidimensional care management. A dietitian and gastroenterologist can direct investigation and make dietary adjustments (for example, modified carbohydrates, adequate fiber but not too much fermentable food).
Fluid balance and sodium
ResearchediPositive results in clinical studies, not yet standard treatment
In cardiac ATTR, heart failure is a central problem. Heart failure medications (diuretics, ACE inhibitors) have consequences for fluid and electrolyte balance. Research from 2026 emphasizes that diuretic dosing and fluid management are crucial parameters for prognosis.
This does not mean that patients must fast strictly or drink extremely little — but fluid intake usually needs to be adjusted in consultation with the cardiologist and dietitian based on symptoms, kidney function and medication regimen. Sodium restriction is generally part of standard advice in heart failure; the degree varies per individual and phase.
Regular meals and gastrointestinal symptoms
ResearchediPositive results in clinical studies, not yet standard treatment
ATTR amyloidosis can be associated with autonomic neuropathy, which affects the gastrointestinal tract: disturbed esophageal motility, early satiety, constipation and diarrhea alternate. Gastroparesis (delayed gastric emptying) is also reported.
This often requires dietary adjustments: smaller, more frequently eaten meals; easy-to-prepare and easy-to-digest food; adequate fluid but not too much at once. A nutrition therapy specialist can work through this step by step, tailored to what the patient can tolerate. This is not one standard diet, but individual problem-solving.
Mediterranean dietary pattern
ResearchediPositive results in clinical studies, not yet standard treatment
The Mediterranean dietary pattern (rich in vegetables, fruit, olive oil, fish, limited meat) is known for its anti-inflammatory and antioxidative properties. In cardiac amyloidosis care, this is sometimes mentioned as a healthy foundation, especially because it may offer heart protection.
Direct research in ATTR populations is lacking, but because inflammation and oxidative stress are present, and this pattern addresses both, it theoretically fits well. The advantage is also that it is sustainable and does not feel like a 'strict diet'. For patients with gastrointestinal complaints, adjustment may be necessary (less rough food, easier to prepare).
Periodic fasting and caloric restriction
UnproveniNo scientific evidence that it works
Fasting and severely restricted caloric intake methods are sometimes promoted in popular nutrition blogs for 'detox' or anti-aging, but for ATTR amyloidosis there is no scientific evidence.
Given that malnutrition and albumin decline are prognostic risk markers, the opposite is likely true: patients should actually ensure adequate nutrition, not less. Radical caloric restriction can lead to severe malnutrition. This pattern is therefore not suitable.
Ketogenic diet
UnproveniNo scientific evidence that it works
The ketogenic diet (very low carbohydrate, high fat) is occasionally offered as a means for nerve repair or metabolic rebalancing, but in ATTR amyloidosis evidence is completely lacking.
Moreover, ketosis offers no benefit for amyloidosis formation specifically, and a strict ketogenic diet can actually lead to disrupted electrolytes, impaired kidney function, and muscle mass loss — all unfavorable in an already vulnerable population. This pattern is not recommended.
---
**Dietary choices in ATTR amyloidosis are highly individualized.** They depend on which form of the disease you have (peripheral, cardiac), which symptoms are dominant (gastrointestinal, heart failure, neuropathy), which medications you take, and your personal medical history. A dietitian with experience in ATTR or amyloidosis can tailor nutrition to your treatment and disease stage. Eat regularly, sufficient protein, and work together with your care providers on adjustments that make sense for your situation — not based on general fad diets.
_This information never replaces a doctor's judgment. Always discuss your situation with your own healthcare provider._